Most US adults with T2D meet criteria for GLP-RAs, SGLT2is

Most U.S. adults with type 2 diabetes (T2D) meet recommended criteria for use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is), but fewer than 10 percent use ...


Prevalence of melatonin supplement use increased over time

(HealthDay)—The reported prevalence of melatonin supplement consumption increased significantly from 1999-2000 to 2017-2018, with prevalence of use of more than 5 mg/day also increasing, starting in 2005 to 2006, according ...


Estimated 1 million individuals living with blindness in the U.S.

(HealthDay)—Roughly 7.1 million people are living with visual acuity loss in the United States; and of these individuals, nearly 1.1 million are living with blindness, according to a meta-analysis published online May 13 ...

Diseases, Conditions, Syndromes

Psoriasis linked to higher risk for thyroid disease

(HealthDay)—Psoriasis is associated with an increased risk for thyroid disease among U.S. adults, according to research published online March 16 in the Journal of the American Academy of Dermatology.

page 1 from 32